90389-96-1

Basic information

• Product Name: 3-(methylaminomethyl)benzonitrile
• Synonyms: 3-(methylaminomethyl)benzonitrile;3-Cyano-N-methylbenzylamine;3-(methylaminomethyl;N-Methyl-N-(3-cyanobenzyl)aMine
• CAS NO: 90389-96-1
• Molecular Formula: C₉H₁₀N₂
• Molecular Weight: 146.19
• Product Categories: Polyamines
• Mol File: 90389-96-1.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 145°C/15mmHg(lit.)
• Flash Point: 103.4 °C
• Appearance: /
• Density: 1.04 g/cm³
• Vapor Pressure: 0.0256mmHg at 25°C
• Refractive Index: 1.5400 to 1.5440
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 3-(methylaminomethyl)benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(methylaminomethyl)benzonitrile(90389-96-1)
• EPA Substance Registry System: 3-(methylaminomethyl)benzonitrile(90389-96-1)

Safety Data

• RIDADR: UN 2922 8/6.1/PG II
• HazardClass: 6.1
• PackingGroup: II
• Hazardous Substances Data: 90389-96-1(Hazardous Substances Data)

Usage

Uses

3-(Methylaminomethyl)benzonitrile is used as pharmaceutical intermediate.

InChI:InChI=1/C9H10N2/c1-11-7-9-4-2-3-8(5-9)6-10/h2-5,11H,7H2,1H3

Upstream product

• 24964-64-5 3-Cyanobenzaldehyde 
• 593-51-1 methylamine hydrochloride 
• 74-89-5 methylamine 
• 42967-27-1 3-[(dimethylamino)methyl]benzonitrile 
• 28188-41-2 m-(bromomethyl)benzonitrile 

Downstream Products

• 133709-01-0 N-(3-Cyanobenzyl)-N-methylformamide 
• 1341536-23-9 tert-butyl (3-cyanobenzyl)methylcarbamate 
• 1262488-44-7 (2-boronobenzyl)-(3-([(2-boronobenzyl)-pyren-1-yl methyl-amino]-methyl)-benzyl)-methyl-amine 

Relevant articles and documents

5-(BIPHENYL-4-YL)-3-PHENYL-1,2,4-OXADIAZOLYL DERIVATIVES AS LIGANDS ON THE SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTORS

The present invention provides compounds of Formula (I), as selective S1 P1 inhibitors, as well as their use for treating multiple sclerosis and other diseases.

OXADIAZOLE DERIVATIVES

The invention relates to compounds of formula (I); wherein R1, R2, Ra, Rb, W, Q and S have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple

DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR

This invention is directed to compounds of formula (I): to pharmaceutical compositions comprising them; to combination products comprising them; and to their use in therapy.